We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CTLT market cap is 10.8B. The company's latest EPS is USD -5.7477 and P/E is -10.40.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.04B | 1.06B | 982M | 1.02B | 1.07B |
| Operating Income | -235M | -126M | -726M | -112M | -36M |
| Net Income | -227M | -110M | -759M | -206M | -101M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.09B | 4B | 4.83B | 4.26B | 4.38B |
| Operating Income | 394.4M | 828M | 755M | -163M | -749M |
| Net Income | 173M | 529M | 503M | -256M | -1.04B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 10.83B | 10.78B | 10.02B | 9.99B | 9.88B |
| Total Liabilities | 6.13B | 6.17B | 6.18B | 6.3B | 6.27B |
| Total Equity | 4.7B | 4.61B | 3.84B | 3.69B | 3.61B |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7.78B | 9.11B | 10.51B | 10.78B | 9.75B |
| Total Liabilities | 4.27B | 4.84B | 5.71B | 6.17B | 6.15B |
| Total Equity | 2.9B | 3.92B | 4.8B | 4.61B | 3.6B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 58M | 254M | -70M | 42M | 54M |
| Investing | -834M | -955M | -84M | -179M | -253M |
| Financing | 572M | 521M | 98M | 84M | 84M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 440.3M | 433M | 439M | 254M | 268M |
| Investing | -827.5M | -649M | -1.88B | -955M | -327M |
| Financing | 1B | 142M | 1.03B | 521M | 74M |
| Market Cap | 10.8B |
| Price to Earnings Ratio | -10.40 |
| Price to Sales Ratio | 2.47 |
| Price to Cash Ratio | 37.52 |
| Price to Book Ratio | 3.01 |
| Dividend Yield | - |
| Shares Outstanding | 181.46M |
| Average Volume (1 week) | 2.59M |
| Average Volume (1 Month) | 1.82M |
| 52 Week Change | 32.08% |
| 52 Week High | 61.20 |
| 52 Week Low | 31.8001 |
| Spread (Intraday) | 1.41 (2.32%) |
| Company Name | Catalent Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.catalent.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
